SDC4 and Huntington disease: Our study generated three major findings: (i) serum syndecan-4 concentration is increased in HD patients compared with controls, (ii) serum syndecan-4 concentration correlated predominantly with geometrical echocardiographic parameters, (iii) serum syndecan-4 level is an independent predictor of both all-cause and CV mortality in HD patients.